CPR Invest - Reactive - R EUR - Acc ISIN : LU1530898177

CPR Invest - Reactive - R EUR - Acc
R(C) - LU1530898177
Asset class: Balanced

YTD
As of 17/11/2026
0.60%

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 17/11/2026
€129.19

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 17/11/2026
€58.92M
This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.

NAVs

NAV from 22/12/2016 to 17/11/2026
Select period
Created with Highcharts 11.4.8CPR Invest - Reactive - R EUR - AccJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '268090100110120130140

Performance

Change in NAV in base 100
FundCPR Invest - Reactive - R EUR - Acc (29.49% over the period)
Select period
Created with Highcharts 11.4.8ACPR Invest - Reactive - R EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2680100120140160
A. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.
FundCPR Invest - Reactive - R EUR - Acc (29.49% over the period)
Select period
Created with Highcharts 11.4.8ACPR Invest - Reactive - R EUR - AccBenchmarkJul '17Jul '18Jul '19Jul '20Jul '21Jul '22Jul '23Jul '24Jul '25Jul '2680100120140160
A. Since the beginning of this period, the reference indicator of the Sub-Fund is the capitalized €STR.Performance published and achieved before the date of the change corresponds to a different strategy from the current one.

Portfolio Analysis

Repartition 10/31/2026
Sector
Weight
AM EURO LIQUIDITY S-T RESP - Z (C)Money Market Investments9.75%
CPR INVEST - CLIMATE BONDS EURO - Z EURInvestment Grade EMU6.55%
AMUNDI EURO LIQUIDITY SELECT - Z (C)Money Market Investments6.18%
AM MSCI WRLD SCREENED UCITS ETF (PAR)Equities World5.46%
abrdn Em Mkt Lcl Ccy Dbt K Acc EURGovies Emerging Global5.41%
CPR ABSOLUTE RETURN BONDS - Z (C)Absolute Return Fixed Income5.35%
Amundi USD Corporate Bond ESG ETF DR CInvestment Grade USA5.18%
CPR INVEST - CREDIXX GLOB HI YIELDHigh Yield World4.72%
ARI - EUROPEAN CREDIT- I2 - CInvestment Grade EMU4.24%
BFT CREDIT OPPORT ISR CLIMAT - I2 (C)Investment Grade Europe3.84%

Management commentary

Effective date: 31/10/2026The month of October was marked by a new surge in energy prices, against a backdrop of persistent geopolitical tensions in the Middle East. Brent crude rose by nearly 14%, while natural gas returned to its highest levels since the end of 2022. This dynamic led to an acceleration in headline inflation in both the eurozone and the United States, without, at this stage, causing a comparable increase in core components. Economic activity remained generally resilient, particularly in the United States, even though the deterioration of the US labor market and the slowdown in European business surveys sent more mixed signals.
 
In this context, the Fed, the ECB, and the Bank of Japan kept their key interest rates unchanged, while maintaining cautious communication in the face of inflationary risks. Bond markets benefited from this monetary pause and a flight to safe-haven assets, resulting in a significant decline in sovereign yields. Conversely, equity markets were shaken at the end of the month by disappointing earnings reports from several major technology companies, which reignited questions about the profitability of massive investments in artificial intelligence. Technology stocks, semiconductors, and emerging markets thus underperformed, while European equities and sectors less exposed to the AI theme proved more resilient.
 
In light of this environment, we maintain a slightly cautious bias on equities. The most concentrated exposures to large US technology stocks, the Nasdaq, and semiconductors have been reduced, as well as certain thematic and emerging market positions. These adjustments aim to limit the sensitivity of allocations to segments with the highest valuation levels and earnings expectations. At the same time, we are favoring broader indices to improve diversification and reduce concentration risk.
From a sector perspective, we are strengthening our preference for healthcare and energy. Healthcare offers more defensive characteristics, better earnings visibility, and relatively limited sensitivity to the economic cycle. Energy, for its part, benefits from rising hydrocarbon prices and serves as a partial hedge against persistent geopolitical and inflationary tensions. Exposure to emerging markets remains more measured, given their sensitivity to the technology sector, the ongoing weakness of Chinese domestic demand, and a still restrictive rate environment.
 
In bond markets, we favor a contained duration, mainly in the five- to seven-year maturities. This positioning allows us to benefit from carry and a potential further easing of yields, while limiting exposure to longer maturities, which are more vulnerable to a renewed rise in inflation expectations. Government bonds also continue to play an important role in diversification and protection in the event of renewed risk aversion in equity markets.
Within credit, the euro investment grade segment remains favored due to the quality of issuers and an always attractive risk-return profile. US high yield also offers an interesting source of carry, but only within a rigorous selection framework, given the level of financing rates and the risks of dispersion among issuers. Finally, emerging market debt in local currencies can provide additional diversification, provided a selective approach is maintained regarding currency, inflation, and monetary policy risks specific to each country.

Characteristics

General data

Inception date
22/12/2016
First Nav Date
22/12/2016
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs1.56% of the value of your investment per year. This percentage is based on actual costs over the last year.€147.73
Transaction costsWe do not charge a transaction fee for this product€0.00
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

20.00% annual outperformance of the reference asset 100% ESTR CAPITALISE (OIS). The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU1530898177
Bloomberg code
CPRRERA LX
Reuters code
LP68406609

Investment Objective

This international diversified sub-fund aims to outperform its benchmark index over a minimum of 4 years with maximum projected volatility of 15%. The portfolio's equity exposure ranges from 20% to 80% and its interest-rate sensitivity from -2 to +5. The sub-fund is a feeder fund for the French mutual fund CPR Croissance Réactive.

Documents

LanguageDocumentsTypeClosing Date
FR
PDF
17/06/2026
PDF
31/07/2025
PDF
03/08/2026
PDF
31/01/2026
FR
PDF
31/10/2026
FR
PDF
26/10/2016
This site does not constitute in any way a solicitation or an offer to buy or sell securities. The information it contains is intended to inform the subscriber by supplementing certain financial characteristics of the OPC appearing in the Key Information Document (KID PRIIPs) or in the prospectus. As a result, this information is inevitably partial and is subject to change. The KID PRIIPs or the prospectus must be offered to subscribers prior to subscription, provided upon subscription and made available to the public upon request, as well as the latest financial statements available.
Data relating to past performance does not take into account any entry fees and exit fees on subscriptions and redemptions of units. These fees may impact past performance.
The funds and securities mentioned above are in no way sponsored, recommended or promoted by the sponsor of the reference index or benchmark used. The sponsor of the reference index or benchmark is not legally and legally responsible for the funds, securities, indices or any funds or securities on which these are based.
References of the local representative or paying agent from whom the legal documents are available free of charge: CACEIS Bank France 1-3, place Valhubert 75013 Paris.